ABBV80.BK AbbVie Inc.

- THB
Market cap
-
P/E
-
P/B
-
ROE
-
Dividend yield
0.69%
Fundamental score
-

Is ABBV80.BK undervalued?

Graham number

The Graham number of AbbVie Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

AbbVie Inc. fundamental analysis

No fundamental analysis for AbbVie Inc. yet.

AbbVie Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About AbbVie Inc.

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung canc…

Full company profile